Paul Lucas is currently Senior Manager in the Global Regulatory CMC function of Amgen Ltd, based in Cambridge U.K. In this role Dr Lucas is a team leader responsible for regulatory strategy for European and Emerging Market filings for development and commercial products in Amgen’s portfolio. Prior to Amgen, Dr Lucas was Research Fellow in the New Products CMC function of the Regulatory CMC group of Pfizer Global Research and Development with global responsibility for regulatory aspects of medical devices and combination products. At Pfizer Dr Lucas was also involved in the late stage development and registration of products both the Pharmaceutical R&D and Regulatory Groups.
Dr Lucas holds a Bachelors degree in Pharmacy form the University of Wales and has been a registered Pharmacist since 1992. He received his PhD on the subject of Gene Transfer to Eukaryotic Cells Using Cationic Polypeptides from the University of Bath, School of Pharmacy and Pharmacology in 1995. Dr Lucas subsequently worked in as a Post-doctoral Research Fellow in the Pharmaceutical Technology group of the same department, where he researched powder technology relating to delivery of inhaled proteins.